ArticleLife (Basel, Switzerland)2023

Identification of Specific Biomarkers and Pathways in the Treatment Response of Infliximab for Inflammatory Bowel Disease: In-Silico Analysis.

Rachid Kaddoura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.